Seventeen cases of “IgG4-positive interstitial pneumonia” characterized by elevated serum IgG4 levels and IgG4-positive plasma cell infiltrations in the lungs

. Komatsu (Matsumoto, Japan), H. Yamamoto (Matsumoto, Japan), S. Matsui (Toyama, Japan), T. Baba (Yokohama, Japan), A. Miyamoto (Tokyo, Japan), T. Handa (Kyoto, Japan), K. Tomii (Kobe, Japan), Y. Waseda (Fukui, Japan), M. Bando (Shimono, Japan), H. Ishii (Tokyo, Japan), Y. Miyazaki (Tokyo, Japan), T. Iwasawa (Yokohama, Japan), T. Johkoh (Amagasaki, Japan), A. Yoshizawa (Kyoto, Japan), Y. Terasaki (Tokyo, Japan), A. Hebisawa (Asahi, Japan), T. Takemura (Yokohama, Japan), Y. Kawabata (Kumagaya, Japan), M. Hanaoka (Matsumoto, Japan), T. Ogura (Yokohama, Japan)

Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
. Komatsu (Matsumoto, Japan), H. Yamamoto (Matsumoto, Japan), S. Matsui (Toyama, Japan), T. Baba (Yokohama, Japan), A. Miyamoto (Tokyo, Japan), T. Handa (Kyoto, Japan), K. Tomii (Kobe, Japan), Y. Waseda (Fukui, Japan), M. Bando (Shimono, Japan), H. Ishii (Tokyo, Japan), Y. Miyazaki (Tokyo, Japan), T. Iwasawa (Yokohama, Japan), T. Johkoh (Amagasaki, Japan), A. Yoshizawa (Kyoto, Japan), Y. Terasaki (Tokyo, Japan), A. Hebisawa (Asahi, Japan), T. Takemura (Yokohama, Japan), Y. Kawabata (Kumagaya, Japan), M. Hanaoka (Matsumoto, Japan), T. Ogura (Yokohama, Japan). Seventeen cases of “IgG4-positive interstitial pneumonia” characterized by elevated serum IgG4 levels and IgG4-positive plasma cell infiltrations in the lungs. 750

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elevated levels of BALF galectin-9 in patients with interstitial pneumonia
Source: Annual Congress 2009 - Airways remodelling
Year: 2009

Elevated levels of serum SP-A in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Serum chitotriosidase levels in granulomatous lung disorders
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


A clinicopathological review of interstitial pneumonia with marked IgG4 positive plasma cells infiltration
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Elevated percentage of hemosiderin-laden macrophages in the BAL fluid of patients with diffuse alveolar damage
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

KL-6 serum levels in adult cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011

KL-6/MUC1 in interstitial pneumonia
Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases
Year: 2005

Elevation of serum tumor markers in patients with interstitial lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


YKL-40 and KL-6 in serum and sputum samples of patients diagnosed with hypersensitivity pneumonitis.
Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases
Year: 2019

Serum and BALF levels of YKL-40 in patients with alveolar proteinosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


Serum KL-6 identifies ILD patients with a progressive fibrosing phenotype
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases
Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis
Year: 2008


Increased BALF eosinophils and underlying interstitial lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Levels of cytokines and chemokines in BAL fluid in patients with idiopathic interstitial pneumonitis and collagen vascular disease associated interstitial pneumonitis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Determination of CD4, CD8 and IL-8 levels in serum and BAL fluid of patients with pulmonary anthracosis
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia
Source: International Congress 2016 – Orphan diseases II
Year: 2016

iNKT cells are inversely related to β-glucan in BALF and granuloma formation in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015

Elevated lPLUNC1 in inflammatory lung disease is due to increased production by goblet cells
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009